Recently, Trust Mutual Life Insurance Company (hereinafter referred to as “Trust Mutual”) signed a cooperation agreement with Beijing Lantian Shared Health Management Co., Ltd. (hereinafter referred to as “Lantian Shared”), a subsidiary of the listed company Chongqing Lummy Pharmaceutical Co., Ltd.
It is understood that the two parties will establish a strategic partnership in the field of thyroid disease health management in China to promote win-win cooperation. In this field, they will leverage their respective strengths to innovate and develop thyroid disease management and tiered payment models through insurance products, explore the establishment of single-disease management and tiered payment solutions, and actively participate in the construction of "Healthy China." Together, they aim to provide superior insurance coverage and more professional, refined health management services for individuals affected by thyroid diseases.
As China’s first mutual life insurance organization, Trust Mutual Life Insurance Company has consistently focused on providing health protection for specific populations. To better address the gap in insurance coverage for individuals with pre-existing conditions, Trust Mutual actively explores collaborations with pharmaceutical companies and professional health management firms, committing to the development of inclusive, large-scale health products. Insurance is no longer merely a form of future protection; instead, through deep integration with upstream and downstream segments of the industry chain and incorporation into real-life scenarios, it creates an integrated health protection model combining “medical care, pharmaceuticals, expenses, and insurance” for users.
Blue Sky Shared, a subsidiary of Lummy Pharmaceutical, is committed to becoming a leader in the niche field of thyroid diseases in China. Leveraging the market dominance of Lummy Pharmaceutical’s core products in the thyroid sector, Blue Sky Shared is expanding its specialized product portfolio for thyroid care while establishing an integrated online-offline professional management system for thyroid diseases through specialized academic institutions.